LPTX Leap Therapeutics Inc

Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

$1.71
As of 06/23/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2017
Outstanding shares:  59,672,014
Average volume:  346,334
Market cap:   $101,442,424
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    52187K101
ISIN:        US52187K1016
Sedol:      BYNS707
Valuation   (See tab for details)
PE ratio:   -3.37
PB ratio:   2.58
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy